NO963052L - Fremgangsmåte for å solubilisere vanskelig opplöselige farmasöytisk aktive komponenter - Google Patents

Fremgangsmåte for å solubilisere vanskelig opplöselige farmasöytisk aktive komponenter

Info

Publication number
NO963052L
NO963052L NO963052A NO963052A NO963052L NO 963052 L NO963052 L NO 963052L NO 963052 A NO963052 A NO 963052A NO 963052 A NO963052 A NO 963052A NO 963052 L NO963052 L NO 963052L
Authority
NO
Norway
Prior art keywords
pharmaceutically active
active components
poorly soluble
soluble pharmaceutically
solubilizing poorly
Prior art date
Application number
NO963052A
Other languages
English (en)
Other versions
NO963052D0 (no
Inventor
Dadi Jamshed Dhabhar
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO963052D0 publication Critical patent/NO963052D0/no
Publication of NO963052L publication Critical patent/NO963052L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Fremgangsmåte for å forbedre oppløseligheten av vanskelig oppløselige farmasøytisk aktive komponenter i en blanding av polyetylenglykol og propylenglykol ved anvendelse av et poly- vinylpyrrolidon med en spesifikk viskositetsmidlere molekyl- vekt på fra omtrent 5.000 til omtrent 25.000.
NO963052A 1994-01-24 1996-07-22 Fremgangsmåte for å solubilisere vanskelig opplöselige farmasöytisk aktive komponenter NO963052L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
PCT/US1995/001018 WO1995019759A1 (en) 1994-01-24 1995-01-24 Process for solubilizing difficultly soluble pharmaceutical actives

Publications (2)

Publication Number Publication Date
NO963052D0 NO963052D0 (no) 1996-07-22
NO963052L true NO963052L (no) 1996-09-24

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963052A NO963052L (no) 1994-01-24 1996-07-22 Fremgangsmåte for å solubilisere vanskelig opplöselige farmasöytisk aktive komponenter

Country Status (14)

Country Link
EP (1) EP0741560A1 (no)
JP (1) JPH09508128A (no)
CN (1) CN1138827A (no)
AU (1) AU706890B2 (no)
BR (1) BR9506564A (no)
CA (1) CA2181241C (no)
CZ (1) CZ210496A3 (no)
FI (1) FI962948L (no)
MX (1) MX9602955A (no)
NO (1) NO963052L (no)
NZ (1) NZ279443A (no)
PL (1) PL315635A1 (no)
SK (1) SK96196A3 (no)
WO (1) WO1995019759A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
ATE429210T1 (de) 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (fr) * 1999-07-29 2003-05-09 So Ge Val Sa Composition antipyretique concentree et stabilisee a usage veterinaire destine a etre incorporee a l'alimentation des animaux ainsi que procede d'incorporation de cette composition a l'eau de boisson d'animaux
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (de) * 2000-03-07 2001-09-13 Bayer Ag Acetylsalicylsäure-Lösungen
KR20020069387A (ko) * 2001-02-26 2002-09-04 진양제약주식회사 호박산독실아민 조성물 및 이 조성물을 함유한 연질캅셀제제
AU2002324579B2 (en) * 2001-07-31 2007-11-15 Wyeth Sucralose formulations to mask unpleasant tastes
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (zh) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 一种难溶性药物微丸的制备方法及包含该微丸的制剂
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
DE102005053066A1 (de) 2005-11-04 2007-05-10 Basf Ag Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen
EP1962908A2 (de) * 2005-12-09 2008-09-03 Basf Se Verwendung von polyvinyllactam-polyoxyalkylen-blockcopolymeren als solubilisatoren für in wasser schwerlösliche verbindungen
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (ja) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd ソフトカプセル
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
SMT201700043T1 (it) 2010-01-28 2017-03-08 Eagle Pharmaceuticals Inc Formulazioni di bendamustina
CN104271135B (zh) 2012-03-20 2017-05-17 赛多斯有限责任公司 在要求减少施用容量的患者中治疗苯达莫司汀响应性状况的方法
JP6250628B2 (ja) 2012-03-20 2017-12-20 イーグル・ファーマシューティカルズ・インコーポレーテッド ベンダムスチンの製剤
NZ709958A (en) * 2013-02-28 2018-03-23 Pfizer Enhanced stability of novel liquid compositions
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (zh) 2015-06-29 2017-06-11 永信藥品工業股份有限公司 一種製作難溶藥物固體劑型的方法
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
CN115957194B (zh) * 2021-10-08 2025-05-16 人福普克药业（武汉）有限公司 一种用于感冒软胶囊中内容物的溶剂体系及感冒软胶囊

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
PL315635A1 (en) 1996-11-25
AU1607595A (en) 1995-08-08
MX9602955A (es) 1997-06-28
FI962948A0 (fi) 1996-07-23
CA2181241A1 (en) 1995-07-27
NO963052D0 (no) 1996-07-22
CZ210496A3 (en) 1996-12-11
FI962948A7 (fi) 1996-07-23
EP0741560A1 (en) 1996-11-13
CA2181241C (en) 2000-04-25
CN1138827A (zh) 1996-12-25
FI962948L (fi) 1996-07-23
JPH09508128A (ja) 1997-08-19
AU706890B2 (en) 1999-07-01
BR9506564A (pt) 1997-09-02
SK96196A3 (en) 1997-03-05
WO1995019759A1 (en) 1995-07-27
NZ279443A (en) 1998-04-27

Similar Documents

Publication Publication Date Title
NO963052L (no) Fremgangsmåte for å solubilisere vanskelig opplöselige farmasöytisk aktive komponenter
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
DK0620828T3 (da) Cyclodextrinderivater med forøget vandopløselighed og anvendelse deraf
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
LU90856I2 (fr) Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
HU9602056D0 (en) Novel pharmaceutical composition containing phenofibrate
EP2016950A8 (en) Pharmaceutical composition comprising an exendin-4 peptide
DZ2172A1 (fr) Dérivés de triazole utiles on thérapeutique, procédé pour leur préparation et compositions les contenant.
AU689817B2 (en) Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
FR2545354B1 (fr) Composition pharmaceutique pour l'administration parenterale a base de nimodipin et procede pour sa preparation
FI910895A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 4-(di-n-propyyli)amino-6-aminokarbonyyli-1,3,4,5-tetrahydrobentso/c,d/indolihippuraatin valmistam iseksi
AU661591B2 (en) 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds
ATE228364T1 (de) Indolalkaloide als antientzündliche wirkstoffe
IL92187A0 (en) Anti-human immunodeficiency virus compositions comprising fluorine-containing pyridonecarboxylic acid derivatives
DK1187611T3 (da) Oftalmiske histaminholdige sammensætninger og anvendelse deraf
DK0557199T3 (da) Polyethylenglycol-hirudin-konjugater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af tromboser
ZA979647B (en) Heterocyclic compounds, compositions and uses.
GR3031118T3 (en) Novel seco-D steroids active in the cardiovascular system and pharmaceutical compositions containing same
IL129627A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129625A0 (en) Novel (-)-enantionmers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IE890275L (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
ATE269693T1 (de) Abführmittel und verfahren zu deren herstellung
IT1257000B (it) Derivati dell'eserolina ad attivita` anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.
MX9703734A (es) Composiciones orales que contienen ondansetron.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application